Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Pleural Effusion, Malignant × tocilizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 6 Lymphoma, Non-Hodgkin 3 Lymphoma 3 Leukemia, Myeloid, Acute 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Solid Tumors 2 Recurrence 2 Melanoma 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, B-Cell 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Uveal Melanoma 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pleural Effusion, Malignant 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neoplasms 1 Myelodysplastic Syndromes 1 Lymphoma, Mantle-Cell 1 Lymphoma, Follicular 1 Fallopian Tube Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Neuroendocrine 1 Carcinoma, Merkel Cell 1 Carcinoma, Hepatocellular 1

Interventions

Trastuzumab 2 Carboplatin 2 Bevacizumab 2 tocilizumab 1 tipifarnib 1 romidepsin 1 lipoplatin 1 aldesleukin 1 Verteporfin 1 Valacyclovir 1 Tyrosine Kinase Inhibitors 1 Sorafenib 1 SPI-77, liposomal 1 Photochemotherapy 1 Pharmaceutical Preparations 1 Paclitaxel 1 LMB-100 1 Interleukin-2 1 Interleukin-12 Subunit p35 1 Interleukin-12 1 Immunotherapy, Adoptive 1 Gemcitabine 1 Erlotinib Hydrochloride 1 Docetaxel 1 Decitabine 1 Dasatinib 1 Cytoreduction Surgical Procedures 1 Bortezomib 1 Afatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06016179 2025-05-22

RIOT2

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Phase 1 Recruiting

Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡